Vidyya Medical News Service
*
Volume 5 Issue 283 Published - 14:00 UTC 08:00 EST 10-Oct-2003 Next Update - 14:00 UTC 08:00 EST 11-Oct-2003
little clear gif used for spacer
.
*

Decreased recurrence: International trial concludes women should take letrozole after five years of tamoxifen treatment
A Canadian-led international clinical trial has found that post-menopausal survivors of early stage breast cancer who took the drug letrozole after completing an initial five years of tamoxifen therapy had a significantly reduced risk of cancer recurrence compared to women taking a placebo. The results of the study appear in an advance on-line edition of the New England Journal of Medicine.  more

*
Information for patients: Questions and answers about Letrozole and breast cancer
Letrozole is a drug that has recently been shown to provide additional protection for women at risk of recurrent breast cancer. A woman who has had breast cancer surgery and received tamoxifen for five years may further reduce her risk by almost 50 percent by taking letrozole.  more

 


*
Rejection hurts
Two key areas of the brain appear to respond to the pain of rejection in the same way as physical pain, a UCLA-led team of psychologists reports in the Oct. 10 issue of Science.  more

*
Antibiotic therapy for Alzheimer's?
The Alzheimer's Association expressed caution about new research on two antibiotics as possible treatments for Alzheimer's disease based on a study presented today at the Annual Meeting of the Infectious Diseases Society of America (IDSA).  more

*
It isn't what you say, it's how you say it: Doctor's communication style sways patient participation in clinical trials
New evidence gathered in a study funded by the National Institute of Environmental Health Sciences suggests that asthmatic children who use maintenance medication are particularly vulnerable to the effects of ground-level ozone, even at levels well below the federal standard set by the Environmental Protection Agency.  more

 
little clear gif used for a space